160 related articles for article (PubMed ID: 10347134)
1. Effects of iron loading on pathogenicity in hepatitis C virus-infected chimpanzees.
Bassett SE; Di Bisceglie AM; Bacon BR; Sharp RM; Govindarajan S; Hubbard GB; Brasky KM; Lanford RE
Hepatology; 1999 Jun; 29(6):1884-92. PubMed ID: 10347134
[TBL] [Abstract][Full Text] [Related]
2. Iron overload in patients with chronic hepatitis C virus infection: clinical and histological study.
Silva IS; Perez RM; Oliveira PV; Cantagalo MI; Dantas E; Sisti C; Figueiredo-Mendes C; Lanzoni VP; Silva A; Ferraz ML
J Gastroenterol Hepatol; 2005 Feb; 20(2):243-8. PubMed ID: 15683427
[TBL] [Abstract][Full Text] [Related]
3. Vaccination of chimpanzees with plasmid DNA encoding the hepatitis C virus (HCV) envelope E2 protein modified the infection after challenge with homologous monoclonal HCV.
Forns X; Payette PJ; Ma X; Satterfield W; Eder G; Mushahwar IK; Govindarajan S; Davis HL; Emerson SU; Purcell RH; Bukh J
Hepatology; 2000 Sep; 32(3):618-25. PubMed ID: 10960458
[TBL] [Abstract][Full Text] [Related]
4. Genetic analysis of serum alanine transaminase activity in normal and hepatitis C virus-infected chimpanzees: an application of research-oriented genetic management.
Williams-Blangero S; Blangero J; Murthy KK; Lanford RE
Lab Anim Sci; 1996 Feb; 46(1):26-30. PubMed ID: 8699815
[TBL] [Abstract][Full Text] [Related]
5. Hepatic iron, liver steatosis and viral genotypes in patients with chronic hepatitis C.
Sebastiani G; Vario A; Ferrari A; Pistis R; Noventa F; Alberti A
J Viral Hepat; 2006 Mar; 13(3):199-205. PubMed ID: 16475996
[TBL] [Abstract][Full Text] [Related]
6. Comparative study between occult hepatitis C virus infection and chronic hepatitis C.
Pardo M; López-Alcorocho JM; Rodríguez-Iñigo E; Castillo I; Carreño V
J Viral Hepat; 2007 Jan; 14(1):36-40. PubMed ID: 17212642
[TBL] [Abstract][Full Text] [Related]
7. Association of hepatitis C virus infection with serum iron status: analysis of data from the third National Health and Nutrition Examination Survey.
Shan Y; Lambrecht RW; Bonkovsky HL
Clin Infect Dis; 2005 Mar; 40(6):834-41. PubMed ID: 15736017
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis C virus kinetics and host responses associated with disease and outcome of infection in chimpanzees.
Major ME; Dahari H; Mihalik K; Puig M; Rice CM; Neumann AU; Feinstone SM
Hepatology; 2004 Jun; 39(6):1709-20. PubMed ID: 15185313
[TBL] [Abstract][Full Text] [Related]
9. Effect of iron depletion on serum markers of fibrogenesis, oxidative stress and serum liver enzymes in chronic hepatitis C: results of a pilot study.
Alexander J; Tung BY; Croghan A; Kowdley KV
Liver Int; 2007 Mar; 27(2):268-73. PubMed ID: 17311623
[TBL] [Abstract][Full Text] [Related]
10. Relationships between plasma ferritin and aminotransferase profile in haemodialysis patients with hepatitis C virus.
Caramelo C; Albalate M; Bermejillo T; Navas S; Ortiz A; de Sequera P; Casado S; Carreño V
Nephrol Dial Transplant; 1996 Sep; 11(9):1792-6. PubMed ID: 8918624
[TBL] [Abstract][Full Text] [Related]
11. Hydroxyoctadecadienoic acid as a potential biomarker for oxidative stress in patients with chronic hepatitis C.
Yoshida Y; Imai Y; Sawai Y; Saito Y; Cao J; Fukuda K; Niki E
J Gastroenterol Hepatol; 2010 Jan; 25(1):107-15. PubMed ID: 19780883
[TBL] [Abstract][Full Text] [Related]
12. Normalization of elevated hepatic 8-hydroxy-2'-deoxyguanosine levels in chronic hepatitis C patients by phlebotomy and low iron diet.
Kato J; Kobune M; Nakamura T; Kuroiwa G; Takada K; Takimoto R; Sato Y; Fujikawa K; Takahashi M; Takayama T; Ikeda T; Niitsu Y
Cancer Res; 2001 Dec; 61(24):8697-702. PubMed ID: 11751387
[TBL] [Abstract][Full Text] [Related]
13. Ribavirin in the treatment of hepatitis C.
Abonyi ME; Lakatos PL
Anticancer Res; 2005; 25(2B):1315-20. PubMed ID: 15865084
[TBL] [Abstract][Full Text] [Related]
14. Liver dysfunction in patients with acute myelogenous leukemia: studies on patients not infected with hepatitis C virus during intense therapy.
Kawatani T; Tajima F; Ishiga K; Suou T; Kawasaki H
J Med; 1998; 29(1-2):45-56. PubMed ID: 9704292
[TBL] [Abstract][Full Text] [Related]
15. gC1qR expression in chimpanzees with resolved and chronic infection: potential role of HCV core/gC1qR-mediated T cell suppression in the outcome of HCV infection.
Yao ZQ; Shata MT; Tricoche N; Shan MM; Brotman B; Pfahler W; Hahn YS; Prince AM
Virology; 2006 Mar; 346(2):324-37. PubMed ID: 16368125
[TBL] [Abstract][Full Text] [Related]
16. Clearance of hepatitis C in chimpanzees is associated with intrahepatic T-cell perforin expression during the late acute phase.
Watanabe H; Wells F; Major ME
J Viral Hepat; 2010 Apr; 17(4):245-53. PubMed ID: 19709361
[TBL] [Abstract][Full Text] [Related]
17. Is serum alanine transaminase level a reliable marker of histological disease in chronic hepatitis C infection?
Sanai FM; Benmousa A; Al-Hussaini H; Ashraf S; Alhafi O; Abdo AA; Alameri HF; Akbar HO; Bzeizi KI
Liver Int; 2008 Aug; 28(7):1011-8. PubMed ID: 18384520
[TBL] [Abstract][Full Text] [Related]
18. Influence of Helicobacter pylori infection on iron accumulation in hepatitis C.
Sumida Y; Kanemasa K; Yamaoka Y; Imamura S; Katoh N; Nakashima T; Tachibana S; Mitsuyoshi H; Itoh Y; Okanoue T
Liver Int; 2006 Sep; 26(7):827-33. PubMed ID: 16911465
[TBL] [Abstract][Full Text] [Related]
19. Adenosine deaminase activity in serum of patients with hepatitis -- a useful tool in monitoring clinical status.
Kaya S; Cetin ES; Aridogan BC; Arikan S; Demirci M
J Microbiol Immunol Infect; 2007 Aug; 40(4):288-92. PubMed ID: 17712462
[TBL] [Abstract][Full Text] [Related]
20. Association between plasma interleukin-18 levels and liver injury in chronic hepatitis C virus infection and non-alcoholic fatty liver disease.
Vecchiet J; Falasca K; Cacciatore P; Zingariello P; Dalessandro M; Marinopiccoli M; D'Amico E; Palazzi C; Petrarca C; Conti P; Pizzigallo E; Guagnano MT
Ann Clin Lab Sci; 2005; 35(4):415-22. PubMed ID: 16254258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
